FDA Inspection
Dompe Farmaceutici S.p.A.Dompe Farmaceutici S.p.A. – FDA Inspection, Sep 20, 2022
Record Details
This FDA Inspection record concerns Dompe Farmaceutici S.p.A., with an inspection on September 20, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Dompe Farmaceutici S.p.A.
- Inspection Date
- September 20, 2022
- Product Type
- Drugs
View Company Profile
ID · 4ee32e43-ffcc-4f85-afc0-86e575229589
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1286070
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Dompe Farmaceutici S.p.A.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 30, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Dompe Farmaceutici S.p.A.
- FDA Inspection 1121884 - 2020-01-30
- FDA Inspection 1055762 - 2018-04-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.